Aripiprazole Oral Solution

DRUG2 trials

Sponsors

Otsuka Beijing Research Institute

Conditions

Autistic DisorderTourette Syndrome

Phase 3

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome

CompletedNCT03487783

Otsuka Beijing Research InstituteTourette Syndrome

Start: 2018-05-02End: 2020-02-14Updated: 2020-12-29

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

CompletedNCT03487770

Otsuka Beijing Research InstituteAutistic Disorder

Start: 2018-04-09End: 2020-04-21Updated: 2020-12-29

Related Papers

Randomized, double-blind, placebo-controlled trial of aripiprazole oral solution in children and adolescents with Tourette’s disorder

Child and Adolescent Psychiatry and Mental Health2024-07-185 citations